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Abstract
Background: Healthy dietary patterns (DPs) have been linked to better cognition and reduced risk of dementia in older
adults, but their role in cognitive functioning and decline in the very old (aged $85 y) is unknown.
Objective: We investigated the association between previously established DPs from the Newcastle 85+ Study and
global and attention-specific cognition over 5 y.
Methods:We followed up with 302 men and 489 women (1921 birth cohort from Northeast United Kingdom) for change
in global cognition [measured by the Standardized Mini-Mental State Examination (SMMSE)] over 5 y and attention
(assessed by the cognitive drug research attention battery) over 3 y. We used 2-step clustering to derive DPs and mixed
models to determine the relation between DPs and cognition in the presence of the dementia susceptibility gene.
Results: Previously, we characterized 3 DPs that differed in intake of red meat, potato, gravy, and butter and varied with key
health measures. When compared with participants in DP1 (high red meat) and DP3 (high butter), participants in DP2 (low
meat) had higher SMMSE scores at baseline (P < 0.001) and follow-ups, and better initial attention (P < 0.05). Membership in
DP1 andDP3was associatedwith overall worse SMMSE scores (b = 0.09,P= 0.01 and b = 0.08, P= 0.02, respectively) than
membership in DP2 after adjustment for sociodemographic factors, lifestyle, multimorbidity, and body mass index (BMI).
Additional adjustment for apolipoprotein (apoE ) e4 genotype attenuated the association to nonsignificant in women but not in
men in DP1 (b = 0.13, P = 0.02). Participants in DP1 and DP3 also had overall worse concentration (b = 0.04, P = 0.002 and
b = 0.028, P = 0.03, respectively) and focused attention (b = 0.02, P = 0.01 and b = 0.02, P = 0.03, respectively), irrespective
of apoE e4 genotype, but similar rate of decline in all cognitive measures over time.
Conclusion: DPs high in red meat, potato, gravy (DP1), or butter (DP3) were associated with poor cognition but not with
the rate of cognitive decline in very old adults. J Nutr doi: 10.3945/jn.115.216952.
Keywords: dietary patterns, global cognition, attention, apoE e4, very old adults, cohort study
Introduction
How to preserve cognitive function and reduce the prevalence
and incidence of dementia in aging populations is of growing
public health concern worldwide (1). Despite some evidence of
declining age-specific rates of the most common subtypes of
dementia, Alzheimer disease (AD)11 and vascular dementia (2),
and intense investigation into the causes of age-related neuro-
degeneration, current pharmacological (e.g., immunotherapy)
and nonpharmacological interventions (e.g., cognitive train-
ing) to slow or prevent cognitive impairment/dementia are
limited (3, 4). Furthermore, risk factors for neurodegeneration
in very old adults (aged $85 y)—who are at the highest risk of
developing poor cognitive health (5)—are unknown (6). In the
general population, advancing age, several genetic factors,
notably apoE e4 genotype, as well as unhealthy lifestyles have
been associated with an increased risk of dementia. For the
latter, accumulated evidence points to the role of overall diet
and of specific dietary components as modulators of cognitive
aging and risk of neurodegenerative diseases (7–11). For
example, inadequate consumption of healthy foods (e.g.,
vegetables and fish) (12, 13), excess intakes of specific nutrients
(e.g., saturated and trans FAs) (14), and excess energy intake
leading to obesity (15, 16) have been linked with more rapid
cognitive decline and to neurodegenerative changes that lead
to dementia in older adults (aged $65 y) (10, 11). Equally,
diets rich in beneficial micro- (e.g., antioxidants) (17, 18) and
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macronutrients (e.g., v-3 FAs) (13), food combinations (19),
and healthy dietary patterns (DPs) derived from data at
hand (20–23) or based on established dietary scores [e.g.,
Mediterranean-style diet (MeDi), Dietary Approaches to Stop
Hypertension Trial (DASH), and combinations thereof] (24–
27, 28–30, 31) may protect against progressive cognitive loss
and dementia.
There is a growing interest in DP analysis in understanding
the impact of nutrition on cognitive decline (32, 33) because DP
is an approach that addresses the complexity of human diet and
the likely synergistic effect of different foods and nutrients on
individual health (34–36). Two main approaches to derive DPs
have been used: a priori (or hypothesis driven) and a posteriori
(exploratory or data driven) approaches (34–36). A priori
developed DPs are based on predefined dietary scores for a
specific DP (e.g., MeDi, DASH, or the Mediterranean-DASH
Intervention for Neurodegenerative Delay diet) (24–31) or
dietary guidelines (e.g., healthy eating index or healthy diet
indicator), in which higher scores indicate healthier DPs, and are
characterized by higher intakes of beneficial foods such as whole
grains, fruits and vegetables, legumes, fish, and olive oil. The
MeDi is recognized for its protective effect against cognitive
decline and dementia (24–27) and other age-related diseases and
conditions (37, 38). The a posteriori approach uses statistical
methods such as factor or cluster analysis (39) to derive DPs and
can take into account the total diet without the need for prior
hypotheses about beneficial or detrimental effects of specific
foods on health.
To date, evidence about the role of DPs in influencing age-
related cognitive decline is inconclusive, leading to limited
recommendations about how nutrition might be used to lower
risk (7–11, 40, 41). Furthermore, few studies investigating the
association between diet/DPs and cognitive decline or de-
mentia have derived DPs empirically (33), or have considered
the role of genetic risk factors in this association (19, 20, 24,
42), especially in very old adults (aged $85). To the best of
our knowledge, the present study is the first prospective study
to explore the association between DPs (derived a posteriori)
and cognitive functioning and decline in very old men and
women, and whether the relation may be changed by apoE
status.
Methods
Participants
TheNewcastle 85+ Study is a longitudinal study of over 1000 individuals
born in 1921, who were recruited through general practices (GPs) in
Newcastle and North Tyneside, United Kingdom as described elsewhere
(43, 44). The study investigated a range of biopsychosocial factors that
may affect physical andmental functioning of very old adults (aged$85)
over a 5-y follow-up. At baseline (2006 and 2007), 851 participants
consented to multidimensional health assessments (including diet and
cognition) and GPs medical records review. Of those, 793 (93.1%) had a
24-h multiple pass dietary recall conducted on 2 nonconsecutive days by
trained research nurses (45) at their usual place of residence (including
care homes), and these dietary data were used to identify DPs as
described previously (46). The analytic sample for the present study
comprised 791 participants [302 (38.2%)men and 489 (61.8%)women]
who had complete diet, health assessment, and GPs records data.
Participants were followed up at 1.5 y (wave 2), 3 y (wave 3), and 5 y
(wave 4) for health and cognitive outcomes.
Ethics
The study was approved by the Newcastle & North Tyneside Local
Research Ethics Committee 1. Written informed consent was obtained
from participants or from a relative or caregiver if individuals lacked
capacity to consent.
Measurements
Cognitive assessments. Global cognitive function was assessed using
the Standardized Mini-Mental State Examination (SMMSE). The
SMMSE is a brief dementia-screening instrument that provides a global
score of cognitive function on a 0 to 30 points scale, with lower scores
indicating worse performance. The assessment follows a standardized
procedure for administration and scoring, and correlates well with the
performance in activities of daily living (47, 48). A total of 788 (99.6%)
out of 791 participants with complete health assessments (including diet)
and GPs record review had baseline SMMSE scores. Global cognitive
function was re-examined at 3-y (wave 3) and 5-y (wave 4) follow-up
(range: 2.9–3.7 y and 4.4–5.6 y, respectively). SMMSE was not collected
at 1.5-y follow-up (wave 2). A total of 463 (58.3%) participants
completed the SMMSE at 3 y, and 328 (41.5%) at 5-y follow-up.
Attention was measured using the attention tasks within a reduced
battery of the cognitive drug research computerized assessment system as
described (49, 50). In brief, attention tasks comprised mean reaction
times (speed scores) of correct responses (in milliseconds) for simple
reaction time (SRT) measuring concentration and alertness, choice reac-
tion time (CRT) examining similar tasks and accounting for additional
information processing speed, and digit vigilance task (DVT) testing
sustained attention while ignoring distractors. Three validated compos-
ite measures derived from these tasks were included: power of attention
(PoA; sum of the 3 attention speed scores) measures focused attention;
reaction time variability (RTV; sum of coefficients of variance of the 3
speed scores) examines attention fluctuation; and continuity of attention
(CoA; combination of the accuracy scores from CRT and DVT) assesses
sustained attention/attention accuracy over the testing period. For all
attention measures except CoA, lower scores indicate better perfor-
mance. A total of 746 (94.3%) participants with complete dietary data
had at least 1 attention task score at baseline. Attention was re-examined
at 1.5- and 3-y follow-up. Details about construction and validation of
composite scores have been described previously (see supplemental
material in 50).
The numbers of participants with complete diet and available
cognitive test scores at each follow-up are summarized in Supplemental
Figure 1.
Dietary assessment. Dietary assessment and validation of 24-h
multiple pass dietary recall in the Newcastle 85+ Study have been
described elsewhere (45, 46). Briefly, trained research nurses evaluated
habitual diet of study participants at baseline by taking a detailed record
of foods eaten on the previous day on 2 different days of the week (except
1 Supported by the National Institute for Health Research Newcastle Biomedical
Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle
University and AXA Carol Jagger Chair of Epidemiology of Ageing. The Newcastle
85+ Study has been funded by the Medical Research Council, Biotechnology and
Biological Sciences Research Council, and the Dunhill Medical Trust. Parts of the
work have also been funded by the British Heart Foundation, Unilever Corporate
Research, Newcastle University, and the North of England Commissioning Support
Unit (formerly National Health Service North of Tyne). The research was also
supported by the National Institute for Health Research Newcastle Biomedical
Research Centre, based at Newcastle upon Tyne Hospitals National Health Service
Foundation Trust and Newcastle University. This is an open access article
distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/).
2 Authors disclosures: A Granic, K Davies, A Adamson, T Kirkwood, TR Hill, M
Siervo, JC Mathers, and C Jagger, no conflicts of interest.
3 The views expressed are those of the authors and not necessarily those of the
National Health Service, United Kingdom.
4 Supplemental Figure 1 and Supplemental Tables 1–3 are available from the
‘‘Online Supporting Material’’ link in the online posting of the article and from the
same link in the online table of contents at http://jn.nutrition.org.
*To whom correspondence should be addressed. E-mail: antoneta.granic@
newcastle.ac.uk.
11 Abbreviations used: AD, Alzheimer disease; CoA, continuity of attention; CRT,
choice reaction time; DASH, Dietary Approaches to Stop Hypertension Trial;
DP, dietary pattern; DVT, digit vigilance task; GP, general practice; MeDi,
Mediterranean-style diet; PoA, power of attention; RTV, reaction time variability;
SMMSE, Standardized Mini-Mental State Examination; SRT, simple reaction time.
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Fridays and Saturdays). About 5% of the study sample had their diets
recalled by proxy. Over 2000 unique food codes were entered into a
Microsoft Access–based dietary data system, and further grouped into
118 food groups based onMcCance andWiddowsons The Composition
of Foods guidelines (46), and expressed as a 2-d mean value (in grams).
These food groups were collapsed into 33 groups based on food and
nutrient composition similarity and categorized as absent or present in
each individuals food intake (coded 0 and 1, respectively). A total of 30
of these food groups (i.e., excluding water, table sugar, and salad
dressings, which were noninformative during clustering) were used in the
cluster analysis as described (46) (Supplemental Table 1).
Covariates. The following covariates from the literature were consid-
ered in multivariate analyses (1, 2, 20–24, 28, 29, 31): 1) sociodemo-
graphic [sex; education (0–9, 10 to 11, $12 y); marital status (not
married, married); social class (routine and manual, intermediate, higher
managerial, and administrative professions)]; 2) lifestyle [diet change in
past year (yes, no); smoking (never, current smoker, former smoker);
physical activity (low, moderate, high)]; 3) health-related factors
[number of chronic diseases (0–1, 2, $3); BMI (in kg/m2): underweight
(<18.5), normal (>18.5–25), overweight (>25–30), obese (>30)]; and 4)
apoE e4 status (no e4 allele, 1+ e4 alleles) (46, 50). Chronic diseases
(multimorbidity) from GP records included arthritis, hypertension,
cardiac disease, respiratory disease, cerebrovascular disease, diabetes,
and cancer (50). Diagnosis of dementia/AD was also determined from
GP records.
Statistical analysis
The SPSS 2-step clustering method used to derive DPs in this cohort
and the associations between DPs and sociodemographic, health, and
functional measures are described elsewhere (46). Briefly, the procedure
creates small preclusters based on a log-likelihood distance criterion (for
categorical variables) in step 1 and agglomerative hierarchical clustering
to merge them into heterogeneous dietary groups in step 2. We used
automatic selection and the Bayesian information criterion to determine
the best DPs solution with 33 food groups, and by excluding food groups
with consistently low importance factors. The smallest Bayesian infor-
mation criterion (goodness of fit measure) was achieved with 30 food
groups, which yielded a 3-DPs solution. The robustness and stability of
the final DPs solution was re-evaluated by random ordering of cases and
by comparing cluster solution characteristics (46).
Cognitive performance by DPs. The differences in raw SMMSE and
attention scores by DPs were compared using the Kruskal-Wallis test for
ordered and nonnormally distributed continuous variables and the chi-
square test for categorical variables (Table 1). All statistics were 2-sided
at a = 0.05.
Global and attention-specific cognition by DPs. SMMSE score was
negatively skewed at each assessment (wave), and thus a transformed
variable [NEWX = log10(30.5 2 X)] was derived and used as a
continuous variable in multilevel models. Lower transformed SMMSE
scores reflect better cognitive performance (i.e., higher original scores).
All attention reaction times were converted into seconds (s) and
logarithmically (log10) transformed to correct a positive skew. PoA and
RTV were also log10 corrected, whereas CoA was negatively skewed
and was transformed as NEWX =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðK 2 XÞp (K = maximum score + 1).
Lower transformed scores for reaction times (SRT, CRT, and DVT) and
PoA, RTV, and CoA indicate better attention.
We used multilevel linear modeling (51) to 1) examine the
association between DPs and SMMSE scores at baseline, 3-y, and 5-y
follow-up, and attention-specific tasks at baseline, 1.5-y, and 3-y
follow-up [coded as 0 (baseline), 1 (1.5 y), 2 (3 y), and 3 (5 y)]; and 2)
identify baseline variables associated with the initial level and the rate
of change in both global cognition and attention over the study period.
This procedure examines simultaneously how each person changes over
time and what predicts difference among people in their change. It
accounts for variances in baseline cognitive level and in varying rate of
change across waves. We fitted a series of linear growth curve models as
follows: 1) with time in study at within-person level (to examine the
linear trend of time), and DPs at between-person levels [to test whether
intercept (initial status) varied by DP], and with an interaction of DPs
and time, to test for varying slopes (rate of change) by DP (Model 1);
and 2) with additional adjustment for baseline time-invariant con-
founders associated with cognition and diet [Model 2 (sociodemo-
graphic, lifestyle, and health-related variables) and Model 3 (apoE e4
genotype)] (Tables 2 and 3). All baseline time-invariant predictors
(fixed effects terms) were categorical, and BMI (7.8% missing values)
was imputed with sex-specific means. Random-effects terms included
both intercepts and slopes of SMMSE and attention scores over time.
We used SPSS mixed procedure (SPSS, 2002) with restricted maximum
likelihood method and autoregressive error covariance matrix (AR1) to
generate parameter estimates (b regression coefficients) with SEs for all
outcomes. b-Coefficients for time represent the change in cognition/
attention over time for the whole population (i.e., an average linear
growth rate). b-Coefficients for DPs show the main cross-sectional
effect of DPs on overall global cognition and attention, and b
coefficient for time and DP interaction represents the change in
cognition/attention over time attributable to DPs. The analyses for
global cognitive decline by DPs were also stratified by sex.
All analyses were conducted using IBM SPSS (V.19 or 21; IBM
Corporation, Armonk, New York).
Sensitivity analysis
We compared participants lost to follow-up, through either withdrawal
or death, with those still in the study 5 y after baseline byMann-Whitney
U test for ordered and nonnormally distributed continuous variables and
by chi-square tests for categorical data (supplemental material).
Mixed models were further adjusted for sex-specific energy quartiles,
supplement intake (yes, no), and number of medications (46, 50).
Cognitive status was also defined as normal (SMMSE raw scores
$26) or impaired (SMMSE raw scores#25) (47, 48, 50) at baseline and
3- and 5-y follow-up. Incident cognitive impairment was defined as
crossing the 25-point threshold of the SMMSE (47, 48, 50), and
cognitive decline as a loss of $3 points from the baseline score (i.e.,
clinically meaningful or reliable change) (52) 3 and 5 y later. We used
several logistic regression models to explore associations between DPs
and prevalent or incident cognitive impairment or decline [OR (95%
CI)] in participants with assigned DPs and baseline cognitive status (n =
788). Models were unadjusted (Model 1), adjusted for sociodemo-
graphic variables (Model 2), and adjusted for other lifestyle and health-
related covariates in Models 3 and 4 (Supplemental Tables 2 and 3).
Covariates with missing data were imputed to the reference values.
Additional adjustments included sex-specific energy quartiles, supple-
ment intake, and number of medications. The models were repeated in a
sample without diagnosis of dementia/AD (from GP records) at baseline
(i.e., 59 participants were excluded from the analysis) and in those living
in the community (i.e., excluding 34 participants living in care homes).
Multicollinearity of confounders was assessed by examining the
correlation matrix and multicollinearity diagnostics (i.e., tolerance,
eigenvalues, and condition index).
Results
We have previously reported 3 distinct DPs [high red meat
(DP1), low meat (DP2), and high butter (DP3)] among partic-
ipants in the Newcastle 85+ Study. These DPs differed in the
participants’ consumption of 8 main food groups (i.e., butter,
unsaturated fats spreads and oils, gravy, potato/potato dishes,
red meat/meat dishes, legumes, coffee, and snacks), and the DPs
were associated with differences in key sociodemographic,
health, and functioning variables (46). Briefly, DP1 (high red
meat) had the highest proportion of participants eating red
meat/meat dishes, gravy, potato/potato dishes, legumes, and
unsaturated fats spreads and the lowest proportion of partici-
pants consuming butter than participants in DP2 and DP3. In
DP2 (low meat), participants did not consume a lot of meats
(i.e., red and processedmeats, bacon and ham, poultry), gravy, and
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potato and food moderate in butter and, when compared with
others, ate the highest proportion of fruits, fish and seafood,
nuts, whole grains and cereal products, low- and high-fat dairy,
soups, and coffee. Therefore, the DP2 group was considered the
healthiest and was used as a referent in present analyses. Unlike
the participants in the other DP groups, participants in the DP3
(high butter) group ate moderate amounts of red meat, and food
high in butter and low in other saturated and unsaturated
TABLE 1 Baseline characteristics and untransformed global cognitive and attention scores in very old
adults by DPs over the study period1
Characteristics All participants DP1: high red meat DP2: low meat DP3: high butter P 2
Participants, n 791 276 260 255
Sex, % (n)
Women 61.8 (489) 57.6 (159) 64.6 (168) 63.5 (162)
Education y, % (n) ,0.001
0–9 64.1 (501) 74.6 (203) 51.9 (134) 65.3 (164)
10–11 23.4 (183) 19.1 (52) 25.2 (65) 26.3 (66)
$12 12.4 (97) 6.3 (17) 22.9 (59) 8.4 (21)
Marital status, % (n) 0.02
Not married 69.4 (548) 66.9 (184) 76.0 (233) 65.5 (167)
Married 30.5 (241) 33.1 (91) 23.9 (62) 34.5 (88)
Social class, % (n) ,0.001
Routine/manual professions 51.1 (305) 58.1 (151) 39.4 (100) 56.1 (134)
Intermediate professions 14.5 (109) 14.2 (37) 15.0 (38) 14.2 (34)
Higher managerial/administrative 34.4 (259) 27.7 (72) 45.7 (116) 29.7 (71)
Cognitive status by SMMSE
Baseline, n 788 273 260 255
Total SMMSE 26.1 6 5.0 25.4 6 5.7 27.3 6 3.3 25.6 6 5.4 ,0.001
Impaired (#25 SMMSE score), % (n) 27.2 (214) 34.4 (94) 18.1 (47) 28.6 (73)
Normal (26–30), % (n) 72.8 (574) 65.6 (179) 81.9 (213) 71.4 (182) ,0.001
Follow-up at 3 y, n 463 144 166 151
Total SMMSE 25.5 6 5.4 25.1 6 5.6 26.2 6 4.8 25.1 6 5.6 0.05
Impaired (#25 SMMSE score), % (n) 33.3 (154) 38.9 (56) 25.9 (43) 35.9 (55) 0.04
Normal (26–30), % (n) 66.7 (309) 61.1 (88) 74.1 (123) 64.1 (98)
Follow-up at 5 y, n 328 99 125 105
Total SMMSE 24.9 6 6.4 25.0 6 6.0 26.2 6 5.2 23.3 6 7.6 0.01
Impaired (#25 SMMSE score), % (n) 34.5 (113) 33.3 (33) 25.8 (32) 45.7 (48) 0.01
Normal (26–30), % (n) 65.5 (215) 66.7 (66) 74.2 (92) 54.3 (57)
CDR attention battery
Baseline, n 746 256 251 239
SRT, ms 473 6 492 510 6 517 418 6 149 493 6 665 0.01
CRT, ms 648 6 351 661 6 305 606 6 189 678 6 496 0.02
DVT, ms 526 6 70 534 6 77 519 6 66 523 6 65
PoA, ms 1613 6 585 1683 6 759 1541 6 383 1614 6 569 0.03
RTV 64 6 20 66 6 22 62 6 17 65 6 20
CoA 52 6 9 50 6 10 53 6 8 52 6 10 0.01
Follow-up at 1.5 y, n 562 182 197 183
SRT 488 6 309 516 6 378 431 6 138 521 6 356 0.02
CRT 663 6 290 676 6 332 611 6 146 706 6 348
DVT 532 6 73 537 6 76 528 6 65 532 6 78
PoA 1682 6 594 1730 6 682 1567 6 286 1758 6 717 0.04
RTV 64 6 21 65 6 23 61 6 13 67 6 25
CoA 52 6 8 53 6 7 52 6 9 52 6 9
Follow-up at 3 y, n 411 122 154 135
SRT 476 6 253 500 6 312 458 6 253 473 6 184
CRT 678 6 371 678 6 345 681 6 461 675 6 267
DVT 534 6 74 535 6 78 536 6 66 542 6 78
PoA 1688 6 624 1713 6 674 1667 6 712 1690 6 452
RTV 63 6 21 63 6 19 63 6 24 64 6 19
CoA 52 6 9 52 6 9 52 6 9 52 6 8
1 All values are means 6 SDs unless otherwise noted. SMMSE and CoA higher scores indicate better performance. SRT, CRT, DVT, PoA,
and RTV lower scores indicate better performance. CDR, cognitive drug research; CoA, continuity of attention (expressed in CoA arbitrary
units); CRT, choice reaction time; DP, dietary pattern; DVT, digit vigilance reaction time; PoA, power of attention; RTV, reaction time
variability; SMMSE, Standardized Mini-Mental State Examination; SRT, simple reaction time.
2 Kruskal-Wallis test for ordered and nonnormally distributed continuous variables.
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fat spreads and oils (Supplemental Table 1) (46). A comparison
of nutritional and blood biomarkers profile across DPs showed
that DP1 had the highest percent energy (E%) from protein and
starch, whereas DP3 had the highest food energy density, total
fat, cholesterol, SFAs, MUFAs, and E% from fat. When
compared with participants in DP1 and DP3, those in DP2
had favorable blood lipid profile (i.e., the lowest total choles-
terol and the highest HDL cholesterol), and were more likely to
be apoE e4 negative. They were also more advantaged in several
socioeconomic indicators (i.e., higher education, social class,
home ownership, and affluence of area of living), were healthier
(i.e., the least likely to be disabled, obese, or depressed and to
have dementia at baseline), and were more physically active
(Supplemental Table 1) (46).
Cognitive performance by DPs
In unadjusted models, participants in DP2 (low meat) had the
highest SMMSE scores at baseline (P < 0.001) and 3-y (P = 0.05)
and 5-y (P = 0.006) follow-ups and thus were the most likely to
be classified as cognitively normal (26–30 SMMSE points) at
all 3 assessments. They also had the best performance on STR
(P = 0.01), CTR (P = 0.02), PoA (P = 0.03), and CoA (P = 0.01)
at baseline, but not 3 y later compared with others (Table 1).
Global cognition by DPs over 5 y
Using multilevel models with the entire cohort, we examined the
association between DPs and SMMSE scores at baseline and at
3- and 5-y follow-ups. The b estimates of SMMSE showed a
significant increase (i.e., poorer performance or cognitive decline)
TABLE 2 Multivariable adjusted b-coefficients of growth curve models for transformed SMMSE scores
over 5 y by DPs in very old adults1
Outcome and effects/variable
Multivariable adjusted
Model 12 Model 23 Model 34
b 6 SE P b 6 SE P b 6 SE P
SMMSE
Entire cohort
Time5 0.10 6 0.03 ,0.001 0.10 6 0.03 ,0.001 0.12 6 0.03 ,0.001
DPs6
DP1 (high red meat) 0.16 6 0.03 ,0.001 0.09 6 0.03 0.01 0.07 6 0.04 0.08
DP2 (low meat) (ref) 0 0 0
DP3 (high butter) 0.14 6 0.03 ,0.001 0.08 6 0.03 0.02 0.03 6 0.04 0.48
DP 3 time7
DP1 3 time 20.01 6 0.04 0.87 20.003 6 0.36 0.94 20.02 6 0.04 0.55
DP2 3 time (ref) 0 0 0
DP3 3 time 1.37E-5 6 0.04 1.0 0.01 6 0.04 0.74 0.01 6 0.04 0.90
Men
Time 0.05 6 0.04 0.28 0.05 6 0.04 0.19 0.09 6 0.04 0.04
DPs
DP1 0.13 6 0.05 0.01 0.10 6 0.05 0.06 0.13 6 0.06 0.02
DP2 (ref) 0 0 0
DP3 0.07 6 0.05 0.16 0.03 6 0.05 0.61 0.01 6 0.06 0.82
DP 3 time
DP1 3 time 0.04 6 0.06 0.51 0.04 6 0.06 0.48 20.01 6 0.06 0.89
DP2 3 time (ref) 0 0 0
DP3 3 time 0.05 6 0.06 0.48 0.07 6 0.06 0.25 0.02 6 0.07 0.75
Women
Time 0.13 6 0.04 ,0.001 0.13 6 0.03 ,0.001 0.13 6 0.04 ,0.001
DPs
DP1 0.17 6 0.04 ,0.001 0.06 6 0.04 0.17 20.01 6 0.05 0.87
DP2 (ref) 0 0 0
DP3 0.18 6 0.04 ,0.001 0.10 6 0.04 0.02 0.02 6 0.05 0.62
DP 3 time
DP1 3 time 20.03 6 0.05 0.56 20.02 6 0.05 0.69 20.03 6 0.05 0.53
DP2 3 time (ref) 0 0 0
DP3 3 time 20.02 6 0.05 0.63 20.02 6 0.05 0.71 20.01 6 0.05 0.89
1 b-Coefficients 6 SEs are estimates of fixed effects using transformed SMMSE longitudinal data [NEWX = log10(30.5 2 X)]. Random-
effects terms included both intercept and slopes of SMMSE scores over time. Time in the study was coded as baseline (0), 3-y follow-up
(1), and 5-y follow-up (2). Increasing (positive) b indicates worse cognitive performance or decline. DP, dietary pattern; ref, reference;
SMMSE, Standardized Mini-Mental State Examination.
2 Model 1 includes a linear trend of time, DPs, and their interaction term.
3 Model 2 is additionally adjusted for sociodemographic (sex, education, marital status, and social class), lifestyle (smoking, physical activity,
and diet change in past year), and health-related variables (multimorbidity, BMI).
4 Model 3 is further adjusted for apoE e4 genotype.
5 The main effect of time across population over 5 y on SMMSE.
6 The main cross-sectional effect of DPs on overall (transformed) mean SMMSE score.
7 Change in SMMSE over time attributable to DPs.
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TABLE 3 Multivariable adjusted b-coefficients of growth curve models for transformed attention tasks
scores over 3 y by DPs in very old adults (entire cohort)1
Outcome and effects/variable
Multivariable adjusted
Model 12 Model 23 Model 34
b 6 SE P b 6 SE P b 6 SE P
SRT
Time5 0.02 6 0.01 ,0.001 0.02 6 0.01 0.01 0.03 6 0.01 0.002
DPs6
DP1 (high red meat) 0.05 6 0.01 ,0.001 0.03 6 0.01 0.003 0.04 6 0.01 0.002
DP2 (low meat) (ref) 0 0 0
DP3 (high butter) 0.03 6 0.03 0.003 0.03 6 0.01 0.02 0.03 6 0.01 0.02
DP 3 time7
DP1 3 time 0.01 6 0.01 0.55 0.01 6 0.01 0.55 0.003 6 0.01 0.73
DP2 3 time (ref) 0 0 0
DP3 3 time 0.01 6 0.01 0.49 0.01 6 0.01 0.41 0.004 6 0.01 0.52
CRT
Time 0.02 6 0.01 0.004 0.02 6 0.01 0.01 0.02 6 0.01 0.002
DPs
DP1 0.03 6 0.01 0.003 0.01 6 0.01 0.21 0.01 6 0.01 0.21
DP2 (ref) 0 0 0
DP3 0.03 6 0.01 0.003 0.01 6 0.01 0.02 0.03 6 0.01 0.01
DP 3 time
DP1 3 time 0.01 6 0.01 0.62 0.01 6 0.01 0.53 0.0002 6 0.01 0.99
DP2 3 time (ref) 0 0 0
DP3 3 time 0.01 6 0.01 0.48 0.01 6 0.01 0.47 0.01 6 0.01 0.96
DVT
Time 0.01 6 0.003 0.03 0.01 6 0.003 0.01 0.01 6 0.003 0.03
DPs
DP1 0.01 6 0.004 0.01 0.01 6 0.004 0.10 0.01 6 0.01 0.15
DP2 (ref) 0 0 0
DP3 0.002 6 0.004 0.65 0.001 6 0.004 0.84 20.001 6 0.01 0.76
DP 3 time
DP1 3 time 4.03E-5 6 0.01 0.01 20.0003 6 0.004 0.95 20.002 6 0.01 0.61
DP2 3 time (ref) 0 0 0
DP3 3 time 0.004 6 0.01 0.36 0.003 6 0.004 0.44 0.003 6 0.01 0.48
PoA
Time 0.02 6 0.01 ,0.001 0.02 6 0.01 0.001 0.02 6 0.01 ,0.001
DPs
DP1 0.03 6 0.01 ,0.001 0.02 6 0.01 0.03 0.02 6 0.01 0.01
DP2 (ref) 0 0 0
DP3 0.02 6 0.01 ,0.001 0.02 6 0.01 0.03 0.02 6 0.01 0.03
DP 3 time
DP1 3 time 0.01 6 0.01 0.23 0.01 6 0.01 0.25 0.004 6 0.01 0.59
DP2 3 time (ref) 0 0 0
DP3 3 time 0.01 6 0.01 0.24 0.01 6 0.01 0.27 0.004 6 0.01 0.60
RTV
Time 0.01 6 0.01 0.47 0.01 6 0.01 0.29 0.01 6 0.01 0.04
DPs
DP1 0.03 6 0.01 0.01 0.02 6 0.01 0.09 0.02 6 0.01 0.06
DP2 (ref) 0 0 0
DP3 0.02 6 0.01 0.03 0.02 6 0.01 0.07 0.02 6 0.01 0.15
DP 3 time
DP1 3 time 20.002 6 0.01 0.87 20.004 6 0.01 0.65 20.01 6 0.01 0.29
DP2 3 time (ref) 0 0 0
DP3 3 time 0.001 6 0.01 0.94 20.001 6 0.01 0.91 20.01 6 0.01 0.25
CoA
Time 0.10 6 0.07 0.17 0.12 6 0.06 0.07 0.15 6 0.07 0.04
DPs
DP1 0.38 6 0.09 0.05 0.20 6 0.09 0.03 0.19 6 0.10 0.07
DP2 (ref) 0 0 0
DP3 0.16 6 0.09 0.001 0.05 6 0.09 0.60 0.0004 6 0.10 0.1
(Continued)
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over 5 y (P < 0.001 in all models), especially in women (P <
0.001) (Table 2). Specifically, the linear growth rate for
SMMSE increased by 0.12 log-transformed SMMSE points per
unit of time in all participants and by 0.13 in women after
adjustment for sociodemographic, lifestyle variables, number
of chronic diseases, BMI, and apoE e4 genotype (Model 3 in
Table 2), indicating cognitive decline with time.
Initial status (intercept) of SMMSE varied significantly by
DPs in the entire cohort and separately in men and women
(Model 1). In the model adjusted for sociodemographic,
lifestyle, and health-related variables (Model 2), both DP1
(high red meat) and DP3 (high butter) were associated with
overall worse SMMSE scores (b 6 SE = 0.09 6 0.03, P = 0.01
and 0.08 6 0.03, P = 0.02, respectively) than DP2 (low meat).
Among women, only DP3 was associated with worse overall
global cognition (0.10 6 0.04, P = 0.02). Adding apoE e4
genotype attenuated these associations to nonsignificant (Model
3), except for DP1 (high red meat) in men (0.13 6 0.06, P =
0.02). However, in all analyses, the interaction term between
DPs and time was nonsignificant, indicating that the slopes (rate
of change) of log-transformed SMMSE means did not vary by
DPs between individuals over 5 y.
In sensitivity analysis, the final model was additionally
adjusted for sex-specific quartiles of energy, supplement intake
(46), and number of medications, which did not change the
results. The conclusions remained in analyses with a sample
without dementia/AD diagnosis (at baseline) and in those living
in the community (data not shown).
Attention-specific tasks by DPs over 3 y
All attention reaction times showed a significant increase over
time (i.e., slower or poorer performance) after adjustment for
potential confounders (including apoE e4 genotype), indicating
within-person decline over 3 y (Table 3). Specifically, mean SRT,
CRT, DVT, PoA, RTV, and CoA increased (slowed) linearly by
0.03, 0.02, 0.01, 0.02, 0.01, and 0.15 log-transformed sec-
onds per measurement occasion (~1.5 y), respectively (Model 3;
all P # 0.04).
In the fully adjusted model (Model 3 in Table 3), both DP1
(high red meat) and DP3 (high butter) were associated with
overall slower reaction times in SRT (alertness/concentration)
and PoA (focused attention/intensity of concentration). Specif-
ically, the log-transformed means of PoA were slower by 0.02
for participants in DP1 (P = 0.01) and DP3 (P = 0.03) than for
those in DP2. Worse performance in focused attention (PoA)
among those in DP1 and DP3 was independent of participants’
poorer attention accuracy (CoA), indicating no intensity of
concentration-accuracy trade-offs (Model 3) (50). Only DP3
was associated with worse overall scores in CRT (information
processing speed), and no association was found for DVT
(sustained attention) or RTV (attention fluctuation). For most
attention tasks (except SRT and PoA), adding physical activity,
BMI, and apoE e4 status to the initial model (Model 1)
attenuated the association between DPs and attention outcome.
For example, both DP1 and DP3 were associated with an
increase in log-transformed RTV (b = 0.02, P = 0.01 for both),
indicating greater fluctuation in attention compared with
participants in DP2. However, the association was attenuated
when adjusted for physical activity (data not shown). DP1 was
associated with worse attention accuracy (CoA) in the model
adjusted for lifestyle (Model 2), but was no longer significant
after adjustment for apoE e4 status.
Additional adjustment for sex-specific quartiles of energy,
supplement use, and number of medications or excluding partic-
ipants living in care homes did not change the conclusions (data not
shown).
Similar to the results for global cognition (SMMSE), the
interaction term between DPs and time was nonsignificant,
indicating that the slopes (rate of change) of attention scores did
not vary by DP over 3 y. Convergence of the models could not be
reached in sex-stratified analysis for most attention outcomes
because of redundant covariance parameters.
Results for sensitivity analysis
DPs and prevalent cognitive impairment (SMMSE). We ob-
served similar results as with multilevel models with transformed
SMMSE (continuous) scores. Of 788 (99.6%) participants with
baseline SMMSE scores and assigned DPs used in logistic
regression models (Supplemental Table 2), 214 (27.2%) were
classified as having impaired cognitive function (SMMSE # 25).
After adjustment for sociodemographic (sex, marital status,
education, social class), lifestyle (smoking, dietary change in the
TABLE 3 Continued
Outcome and effects/variable
Multivariable adjusted
Model 12 Model 23 Model 34
b 6 SE P b 6 SE P b 6 SE P
DP 3 time
DP1 3 time 20.03 6 0.10 0.76 20.03 6 0.09 0.73 20.06 6 0.10 0.54
DP2 3 time (ref) 0 0 0
DP3 3 time 0.03 6 0.10 0.77 0.04 6 0.09 0.64 20.01 6 0.10 0.89
1 b-Coefficients6 SEs are estimates of fixed effects using transformed longitudinal data for all attention tasks [all log10 transformed except
CoA, which was transformed as NEWX =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðK 2 XÞp , K = maximum score +1]. Random-effects terms included both intercept and slopes of
attention scores over time. Time in the study was coded as baseline (0), 1.5-y follow-up (1), and 3-y follow-up (2). Increasing (positive) b
indicates worse attention or decline in attention. CoA, continuity of attention (expressed in CoA arbitrary units); CRT, choice reaction time;
DP, dietary pattern; DVT, digit vigilance reaction time; PoA, power of attention; ref, reference; RTV, reaction time variability; SMMSE,
Standardized Mini-Mental State Examination; SRT, simple reaction time.
2 Model 1 includes a linear trend of time, DPs, and their interaction term.
3 Model 2 is additionally adjusted for sociodemographic (sex, education, marital status, and social class), lifestyle (smoking, physical activity,
and diet change in past year), and health-related variables (multimorbidity and BMI).
4 Model 3 is further adjusted for apoE e4 genotype.
5 The main effect of time across population over 3 y on attention.
6 The main cross-sectional effect of DPs on overall (transformed) mean attention scores.
7 Change in attention over time attributable to DPs.
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past year), and health factors (BMI, multimorbidity) (Model 3),
participants in both DP1 (high red meat) and DP3 (high butter)
had increased odds of cognitive impairment than participants in
DP2 (low meat) (OR: 2.30; 95% CI: 1.50, 3.54; P < 0.001 and
1.70; CI: 1.10, 2.64; P = 0.02, respectively). The association was
no longer significant by additional adjustment for physical
activity and depressive symptoms for those in DP3, but not for
participants in DP1 (1.91; CI: 1.22, 3.01; P = 0.01), which
remained significant after additional adjustment for sex-specific
total energy, and apoE e4 genotype (1.81; CI: 1.08, 3.01; P =
0.02). Similar results were obtained when individuals with
dementia/AD diagnosis (from GP records) were excluded from
the models (n = 59) (Supplemental Table 3). DP1 was associated
with a 74% increased risk of cognitive impairment (P = 0.03)
compared with DP2 after adjustment for all covariates (Model
4), but it was attenuated by apoE e4 genotype (1.63; CI: 0.95,
2.79; P = 0.07) (data not shown). Adding supplement intake and
number of medications to the models did not change the
conclusions or when we excluded those residing in care homes
from the models (n = 34) (data not shown).
DPs and incident cognitive impairment and decline over 3
and 5 y. We used similar models as for the prevalent cognitive
impairment to investigate the relation between DPs and incident
cognitive impairment and decline. The incident impairment was
defined as crossing a 25-point SMMSE cut-off, and decline as a
loss of $3 SMMSE points (52) over 3- and 5-y follow-up.
Significant associations between DPs and cognitive decline of$3
SMMSE were observed at 5-y follow-up (Supplemental Table 3)
but not for incident cognitive impairment 3 and 5 y after
baseline. DP3 (high butter) was associated with a 3.2-fold
increased risk of cognitive decline (P = 0.001) in the fully
adjusted model (Model 4), which was not changed by apoE
status, sex-specific total energy, supplement intake, and number
of medications in those free of dementia at baseline and residing
in the community (data not shown).
Discussion
Using multilevel models, we investigated the association be-
tween previously defined DPs (46) and global and attention-
specific cognition in very old participants of the Newcastle 85+
Study. We found that DP1 (high red meat), a diet represented by
a higher intake of red meat/meat dishes, gravy, and potato, or
DP3 (high butter), a diet high in butter and low in unsaturated
fat spreads/oils, was associated with worse overall attention in
the very old, than DP2 (low meat), a diet low in red/processed
meat, gravy, and potato and high in fish, fruits, nuts, dairy, and
whole grain products. Specifically, participants in DP1 or DP3
had worse concentration (SRT), information processing speed
(CRT), and focused attention (PoA) than participants in DP2,
irrespective of apoE e4 status and other key covariates. On the
other hand, the association between DP1 and DP3 and global
cognition was attenuated to nonsignificant by apoE e4 genotype
in the entire cohort and in women (DP3), but not in men (DP1).
However, the magnitude of these associations was very small
and may not convey clinical importance. In addition, the rate of
cognitive change (both global and attention specific) was not
affected, indicating that participants in all 3 DPs experienced
similar rate of cognitive decline over 5 y, although those in DP2
had reached very old age in better cognitive form than others.
When global cognitive decline was defined as a loss of$3 SMMSE
points over 5 y (representing clinically meaningful change) (52),
the risk was 3-fold higher in participants belonging to DP3 and
was not reduced by apoE e4 status.
The extent to which DPs play a role in cognitive function and
decline, and the risk of dementia, in the very old (aged$85) has
not been investigated separately. Furthermore, the role of apoE
e4 genotype in cognition-DP association is poorly understood. In
addition, methodological differences in dietary assessments, DP
derivation, cognitive tests, and definition of cognitive outcomes
(e.g., impairment, decline, dementia/AD) across the studies
preclude direct comparison of findings. However, certain sim-
ilarities with our findings pertaining to more or less beneficial
DPs (derived a posteriori) for cognitive health in late life may be
highlighted.
For example, in the New York–based study of over 2000
older adults (mean age of 77.2 y) the middle and the highest
tertiles of a DP that negatively correlated to red or organ meats
and butter and positively correlated to fish, nuts, fruits, and
cruciferous/green leafy vegetables were associated with 19%
and 38% decreased risk of AD compared to the lowest tertile
over 4 y and were not attenuated by apoE e4 status (19). This DP
bears similarities with DP2, which had the highest percentage of
participants consuming potentially more beneficial foods (e.g.,
fish, fruits, nuts, and whole grain and cereal products) and the
lowest intake of red and processed meats (46). Participants in
DP2 had the highest SMMSE scores at each assessment over 5 y
and better initial attention. In the 3-City cohort study of over
8000 older French (aged $65), only apoE e4 noncarriers
benefited from DPs characterized by daily intake of fruits and
vegetables, and weekly consumption of fish, and had a 2-fold
increased risk of AD if the consumption of n–6 PUFA rich-oils
was not counteracted by n–3 PUFA food sources (20). In our
study, men belonging to DP1 characterized by the highest intake
of red meat/meat dishes, gravy (sources of SFAs and MUFAs),
and unsaturated fats, spreads, and oils (sources of MUFAs and
PUFAs) but low in fish/seafood (source of n–3 PUFAs) had
overall worse global cognition irrespective of apoE e4 gene and
other important covariates. This suggests that in this DP the
negative effect of less healthy fats (e.g., SFAs) (14) in the
presence of other beneficial nutrients (e.g., vitamin B-12) from
red meat (53) and insufficient amounts of healthy FAs (e.g.,
PUFAs) (7–10, 13) from other food sources may predispose older
adults to worse cognition regardless of genetic risk factors.
Similarly, participants in DP3, which had the highest consump-
tion of total fat, cholesterol, SFAs, and MUFAs (but not PUFAs)
from mainly butter and red/processed meat and bacon/ham and
not from unsaturated fats, spreads, oils, and fish (sources of
PUFAs) were at a higher risk of cognitive decline (defined as a
loss of $3 SMMSE points) over 5 y and had worse overall
attention regardless of apoE e4, total energy, number of
medications, and dementia status at baseline compared with
DP2 (sensitivity analysis). Therefore, when diet-cognitive health
hypothesis is tested, a low or high consumption of a certain food
or nutrient (a single food/nutrient approach) may reveal incom-
plete information without consideration of other foods/nutrients
and their synergistic or antagonistic effect on the outcome (a
whole diet/DP approach).
Several biological mechanisms may play a role in less
favorable cognitive outcomes in older adults belonging to DP1
and DP3. For example, DPs high in foods rich in saturated fats
may raise the risk of poor cognition by disrupting peripheral and
brain lipid homeostasis, which in turn may affect neuronal
membrane properties, synaptic plasticity, and signal transduc-
tion of neurons and increase the production of amyloid-beta
(Ab)—a hallmark of AD pathology (14, 54). Because the a
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posteriori approach accounts for a synergistic effect of other
food groups and nutrients, this potential negative effect of
saturated fats on cognition happens in the presence of more
beneficial FAs (i.e., MUFAs in DP3) and in conjunction with
other foods such as potato/potato dishes with high glycemic
index (55) (i.e., DP1 had the highest E% from starch and
carbohydrates) (46). This combination may in turn exacerbate
fat-induced insulin resistance and decreased insulin sensitivity in
the brain, and impaired clearance of Ab peptide across the brain-
blood barrier (56), to which the very old brain with excess
vascular pathology may be particularly susceptible.
The results presented here should be interpreted with caution
for several reasons. Although, to our knowledge, this is the first
prospective evaluation of the DP-cognitive decline relation in the
very old living independently and in care homes, diet was assessed
only at baseline, which might not represent a stable diet over the
study period. Seasonal variation of foods and exclusion of food
recall on Fridays and Saturdays may have biased DP solution, and
averaging 2-d recalls of food intake may have misrepresented
habitual diet. Although we excluded those with dementia
diagnosis (from GP records) in sensitivity analyses and confirmed
the results, predementia states might have affected dietary choices
before assessment of cognitive function. Prospective cognitive
evaluation was limited to global cognition (i.e., SMMSE) and
attention. Although we also considered a loss of $3 SMMSE
points as a reliable, clinically relevant cognitive decline (52) in
relation to DPs over 5 y, the log-transformed b estimates in mixed
models were small and hard to interpret, andmay not be clinically
meaningful. Although the cognitive drug research attention
battery has the ability to detect the change in attention with
millisecond precision, the interpretability and the clinical rele-
vance of detected change may be challenging. In a validation
study (57), a decline of 59 ms in focused attention (PoA) over
6 mo in patients with a diagnosis of very mild AD (>26 Mini-
Mental State Examination) and treated with cholinesterase
inhibitors has been considered as clinically important. Partici-
pants in DP3 slowed by 144 ms (raw scores) in PoA over 18 mo
(1.5 y) compared with 26 ms in those belonging to DP2, which
may represent a clinically relevant decline. However, the rate of
cognitive decline did not differ by DPs, possibly due to loss of
power or selection bias. By 5-y follow-upwe lost about half of our
cohort (58), which might have introduced selection bias of very
robust oldest-old survivals—affecting significant findings in cross-
sectional analyses. The association between DP1 and DP3 and
worse cognition may be contributed to uncontrolled confounding
(e.g., oral health, food environment, and medication interaction).
Finally, the results may have limited generalizability outside a
white population of North European descent. The strengths of
our study include its prospective design; representativeness of the
United Kingdom population (including those in care homes);
validated dietary assessment (45); robustness of clustering tech-
nique used to derive DPs, which considers whole diet (46);
validated attention-specific cognitive measures (49, 50); and
adjustment for several putative risks for cognitive decline/
dementia including the apoE e4 status.
In conclusion, we have found the association between a
posteriori–derived DPs (DP1, a high red meat, or DP3, high
butter) and worse overall global cognition (in men) and
attention after adjusting for several risk factors including apoE
e4 genotype. However, the rate of cognitive decline was not
affected by DPs. Diets high in red/processed meat, gravy, and
potato/potato dishes or butter may predispose to cognitive
impairment in very old adults. The finding needs to be further
explored and validated in other prospective cohort studies to
establish a causal link between a DPs dominated with foods rich
in fats/cholesterol and cognitive function in very late life.
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